Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hamm

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Medical and Physical Journal|November 30, 2018
History of a Case of Hydrocephalus Internus, in Which Copious Depletion by the Lancet, &c. Was Successfully EmployedJohn Hamm
Harvard Business Review|January 4, 2003
Why entrepreneurs don't scaleJohn Hamm
Harvard Business Review|May 3, 2006
The five messages leaders must manageJohn Hamm
Journal of Neurology|January 17, 2003
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)Heiko Braak, Kelly Del Tredici, Hansjürgen Bratzke, et al.
Future Science OA|November 20, 2024
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumabJared Weiss, Douglas Laux, David Bajor, et al.
Surgery|July 8, 2020
A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinomaConor O'Neill, Traci Hayat, John Hamm, et al.
Audiology & Neuro-Otology|April 9, 2008
Testing the diagnostic value of electrical ear canal stimulation in cochlear implant candidates by functional magnetic resonance imagingKatrin Neumann, Christine Preibisch, Joachim Spreer, et al.
Cancer Chemotherapy and Pharmacology|July 31, 2007
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinomaE Gabriela Chiorean, Tomislav Dragovich, John Hamm, et al.
Investigational New Drugs|February 17, 2017
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)Susanne M Arnold, Kari Chansky, Markos Leggas, et al.
Molecular and Cellular Neurosciences|October 24, 2003
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formationSuzana Gispert, Domenico Del Turco, Lisa Garrett, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Medical and Physical Journal|November 30, 2018
History of a Case of Hydrocephalus Internus, in Which Copious Depletion by the Lancet, &c. Was Successfully EmployedJohn Hamm
Harvard Business Review|January 4, 2003
Why entrepreneurs don't scaleJohn Hamm
Harvard Business Review|May 3, 2006
The five messages leaders must manageJohn Hamm
Journal of Neurology|January 17, 2003
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)Heiko Braak, Kelly Del Tredici, Hansjürgen Bratzke, et al.
Future Science OA|November 20, 2024
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumabJared Weiss, Douglas Laux, David Bajor, et al.
Surgery|July 8, 2020
A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinomaConor O'Neill, Traci Hayat, John Hamm, et al.
Audiology & Neuro-Otology|April 9, 2008
Testing the diagnostic value of electrical ear canal stimulation in cochlear implant candidates by functional magnetic resonance imagingKatrin Neumann, Christine Preibisch, Joachim Spreer, et al.
Cancer Chemotherapy and Pharmacology|July 31, 2007
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinomaE Gabriela Chiorean, Tomislav Dragovich, John Hamm, et al.
Investigational New Drugs|February 17, 2017
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)Susanne M Arnold, Kari Chansky, Markos Leggas, et al.
Molecular and Cellular Neurosciences|October 24, 2003
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formationSuzana Gispert, Domenico Del Turco, Lisa Garrett, et al.
Pageof 2